1Humar A, Snydman D, AST Infectious Diseases Community of Practice. Cytomegalovirus in solid organ transplant recipients[J]. Am J Transplant,2009,9 (4): 78-86.
2De Keyzer K, Van Laecke S, Peeters P, et al. Human cytomegalovirus and kidney transplantation: a clinician’s update[J]. Am J Kidney Dis, 2011, 58(1): 118-126.
4Fortun J, Martin-Davila P, Pascual J, et al. Immunosuppressive therapy and infection after kidney transplantation[J]. Transpl Infect Dis, 2010, 12(5): 397-405.
5Tian JH, Wang X, Yang KH, et al. Induction with and without antithymocyte globulin combined with cyclosporine/tacrolimus-based immunosuppression in renal transplantation: a meta-analysis of randomized controlled trials[J]. Transplant Proc, 2009 , 41(9): 3671-3676.
6Prichard MN, Kern ER. The search for new therapies for human cytomegalovirus infections[J]. Virus Res, 2011, 157(2): 212-221.
8Crough T, Khanna R. Immunobiology of human cytomegalovi-rus: from bench to bedside[J]. Clin Microbiol Rev, 2009, 2(1): 76-98.
9Razonable RR, Paya CV. Herpesvirus infections in transplant recipients: current challenges in the clinical management of cytomegalovirus and epstein-barr virus infections[J]. Herpes, 2003, 10(3): 60-65.
1Muller GA,Muller CA,Einsele H.Cytomegalovirus infection:how to manage it in the immunoeompromised transplant recipient[J]? Nephrol Dial Transplant,1994,9(1):3-4.
2Motta VN,Martins SL.Impairment of eytomegalovims-specific cellular immune response as a risk factor for cytomegalovirus disease intransplant recipients[J].Braz J Med Biol Res,2008,41(1):5-11.
3Carstens J,Andersen HK,Spencer E et al.Cytomegalovims infection in renal Ixansplant recipients[J].Transpl Infect Dis,2006,8(4):203-12.
4Sehnitzler MA.Costs and consequences of cytomegalovirus disease[J].Am J Health Syst Pharm,2003,60(8):S5-8.
5Abbott KC,Hypolite IO,Viola R,et al.Hospitalizations for eytomegalovims disease after renal transplantation in the United statas[J].Ann Epidemiol,2002,12(6):402-9.
6Nashan B.Early clinical experience with a novel rapamyein derivative[J].TherDrug Monit,2002,24(1):53-8.
8Hummel M,Zhang Z,Yah S,et al.Allogeneic transplantation induces expression of cytomegalovirus immediate-early genes in vbJo:a model for reactivation from latency[J].J Virot,200I,75(10):4814-22.
3Kalil AC,Levitsky J,Lyden E,et al.Meta-analysis:the efficacy of strategies to prevent organ disease by cytomegalovirus in solid organ transplant recipients[J].Ann Intern Med,2005,143(12):870-880.
4Schroeder RB,Michelon TF,Garbin G,et al.Early HHV-6 replication is associated with morbidity non-related to CMV infection after kidney transplantation[J].Braz J Infect Dis,2012,16(2):146-152.
5Lochmanova A,Lochman I,Tomaskova H,et al.Qua-ntiferon-CMV test in prediction of cytomegalovirus infection after kidney transplantation[J].Transplant Proc,2010,42(9):3574-3577.
